UNH
Unitedhealth Group Inc
$424.62
-7.06 (-1.64%)
At close · Jul 10
Market Cap
$385.62B
Shares
908,144,404
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$424.62
Open$431.67
Day$423.65–432.86
52W$229.79–434.30
Avg vol 30d6.1M
Short int18.4M · 2.0% float · 2.7d
Short vol46%
Last earningsApr 21, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 5
Up next
Next earnings call
Jul 21, 2026
Est · unconfirmed
· in 1 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 5, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Moderate
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+25%
above
Price vs 50-day avg
+7%
above
RSI (14)
60
neutral
MACD trend
Negative
52-week position
95%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+4%
trailing
6-month return
+26%
trailing
YTD return
+30%
this year
Relative strength
+17%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $397 › 200d $339 — 50d above 200d
Institutional flow
Accumulating
197 of 3,036 funds reported for Jun 30 · net +674.3K sh shares · +26 new
Insider flow
Distributing
Net -$284.0K over 90 days · 100% sells
Short interest
Rising
2.03% of float · ▲ +7.2% MoM · 2.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
3,036 holders — near 3-yr low, contrarian setup
Squeeze score
58
elevated · 0–100
Fundamentals
Revenue growth
+12%
Y/Y
EPS growth
−15%
Y/Y
Free cash flow
$16.1B
Valuation
P/E 32
below peers
Balance sheet
$51.6B
net debt
Quant / Vol
risk profile
Volatility
40%
annualized · 1-yr
Max drawdown
−29%
past year
ATR
2.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+25%
Bullish
Price vs 50-day avg
+7%
Bullish
RSI (14)
60
Neutral
MACD trend
Negative
Bearish
52-week position
95%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $397 › 200d $339 — 50d above 200d
Institutional flow
Accumulating
197 of 3,036 funds reported for Jun 30 · net +674.3K sh shares · +26 new
Insider flow
Distributing
Net -$284.0K over 90 days · 100% sells
Short interest
Rising
2.03% of float · ▲ +7.2% MoM · 2.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
3,036 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $230
Now $425 · 95%
52-wk high $434
vs 200-day avg +25%
vs 50-day avg +7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted net earnings per share non-GAAP | $7.23 | First Quarter 2026 | — |
| Days claims payable | 48.6 | First Quarter 2026 | — |
| Days sales outstanding | 21.6 | First Quarter 2026 | — |
| Debt-to-capital ratio | 42.9% | First Quarter 2026 | — |
| Medical care ratio | 83.9% | First Quarter 2026 | — |
| Operating cost ratio | 13.8% | First Quarter 2026 | — |
| Optum consumers served | 122M | First Quarter 2026 | — |
| Optum Health adjusted operating earnings non-GAAP | 1.3B | First Quarter 2026 | — |
| UnitedHealthcare consumers served | 49.1M | First Quarter 2026 | — |
| care provider digital transaction volume growth year-over-year | 75% | Q1 2026 call | — |
| consumer contacts through digital formats | 80% | Q1 2026 call | — |
| digital visits | 73M | Q1 2026 call | — |
| digital visits growth over last two years | 42% | Q1 2026 call | — |
| electronic prior authorization requests processed in real-time | 50% | Q1 2026 call | — |
| in-network providers using portal or API tools | 75% | Q1 2026 call | — |
| prior authorization requests approved on average in one business day | 90% | Q1 2026 call | — |
| prior authorization requests submitted electronically | 95% | Q1 2026 call | — |
| Adjusted Earnings from Operations non-GAAP | $21.7B | Full Year 2025 | — |
| adjusted medical care ratio non-GAAP | 88.9% | Full Year 2025 | — |
| adjusted operating cost ratio non-GAAP | 12.9% | Full Year 2025 | — |
| consumers served | 49.8M | Full Year 2025 | — |
| people served | 49.8M | Full Year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Healthcare Plans — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
UNH
this stock
Unitedhealth Group Inc
|
$385.62B | +29.6% | +11.8% | 32.0 | 2.0% |
|
CVS
CVS HEALTH Corp
|
$132.89B | +32.3% | +10.9% | 45.7 | 1.6% |
|
ELV
Elevance Health, Inc.
|
$90.39B | +19.5% | +9.4% | 17.6 | 2.8% |
|
CI
Cigna Group
|
$77.63B | +7.2% | +11.2% | 12.4 | 2.4% |
|
HUM
Humana Inc
|
$47.09B | +53.9% | +10.1% | 41.9 | 3.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| UNH | -0.2% | +4.2% | +26.3% | +2.2% | +29.6% |
| SPY | +1.4% | +4.1% | +9.1% | +1.1% | +10.7% |
| vs SPY | -1.5% | +0.1% | +17.2% | +1.1% | +18.9% |
Capital returns
Latest dividend
$2.32
/ share · ex Jun 15, 2026
Paid (TTM)
$8.95
/ share · 4 payouts
Dividend yield (TTM, derived)
2.11%
Buyback program
· as of Dec 31, 2025
Authorized
shares 35.00M
Spent (derived)
shares 14.00M
Remaining
shares 21.00M
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.